Investigational MRI Clinical Software and Hardware
ConditionImage, Body
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-90
SponsorNorthwestern University
About this trial
Patients and healthy volunteers will be scanned in order to test new sequences.
Eligibility criteria
Qualifiers
• At least 18 years of age
Able to complete the MR safety questionnaire.
Able to comprehend and provide informed consent in English.
When contrast is being administered: healthy volunteers with a GFR≥60 ml/min
Disqualifiers
• When contrast is being administered: subjects with a GFR < 30 ml/min
When contrast is being administered: subjects with acute kidney injury
When contrast is administered, allergy to gadolinium-containing contrast media
Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)
Trial design
Treatments tested in this trial
- MRI
- Gadavist 2Ml Solution for Injection
Treatment groups
2,000 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov